A detailed history of Rock Springs Capital Management LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 263,062 shares of MDGL stock, worth $77.2 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
263,062
Previous 245,499 7.15%
Holding current value
$77.2 Million
Previous $68.8 Million 18.83%
% of portfolio
1.9%
Previous 2.13%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$212.22 - $292.96 $3.73 Million - $5.15 Million
17,563 Added 7.15%
263,062 $55.8 Million
Q2 2024

Aug 14, 2024

SELL
$193.33 - $291.99 $7.82 Million - $11.8 Million
-40,432 Reduced 14.14%
245,499 $68.8 Million
Q1 2024

May 15, 2024

BUY
$171.37 - $283.23 $15 Million - $24.9 Million
87,762 Added 44.29%
285,931 $76.4 Million
Q4 2023

Feb 14, 2024

BUY
$120.4 - $237.13 $216,720 - $426,834
1,800 Added 0.92%
198,169 $45.9 Million
Q3 2023

Nov 14, 2023

SELL
$146.04 - $225.78 $416,067 - $643,247
-2,849 Reduced 1.43%
196,369 $28.7 Million
Q2 2023

Aug 14, 2023

SELL
$203.88 - $312.0 $30.4 Million - $46.5 Million
-148,903 Reduced 42.77%
199,218 $46 Million
Q4 2022

Feb 14, 2023

BUY
$58.39 - $296.54 $1.79 Million - $9.08 Million
30,636 Added 9.65%
348,121 $101 Million
Q2 2022

Aug 15, 2022

BUY
$58.04 - $100.2 $2.55 Million - $4.41 Million
43,985 Added 16.08%
317,485 $22.7 Million
Q1 2022

May 16, 2022

BUY
$55.89 - $101.89 $229,149 - $417,749
4,100 Added 1.52%
273,500 $26.8 Million
Q4 2021

Feb 14, 2022

BUY
$72.34 - $95.09 $499,146 - $656,121
6,900 Added 2.63%
269,400 $22.8 Million
Q2 2021

Aug 16, 2021

BUY
$97.2 - $137.59 $388,800 - $550,360
4,000 Added 1.55%
262,500 $25.6 Million
Q1 2021

May 17, 2021

BUY
$108.54 - $125.2 $187,991 - $216,846
1,732 Added 0.67%
258,500 $30.2 Million
Q4 2020

Feb 16, 2021

BUY
$110.06 - $133.7 $275,150 - $334,250
2,500 Added 0.98%
256,768 $28.5 Million
Q2 2020

Aug 14, 2020

BUY
$60.13 - $125.71 $256,634 - $536,530
4,268 Added 1.71%
254,268 $28.8 Million
Q1 2020

May 15, 2020

SELL
$66.76 - $93.49 $13,352 - $18,698
-200 Reduced 0.08%
250,000 $16.7 Million
Q4 2019

Feb 14, 2020

SELL
$84.28 - $118.5 $1.87 Million - $2.63 Million
-22,200 Reduced 8.15%
250,200 $22.8 Million
Q3 2019

Nov 14, 2019

BUY
$84.4 - $106.53 $1.31 Million - $1.65 Million
15,500 Added 6.03%
272,400 $23.5 Million
Q2 2019

Aug 14, 2019

BUY
$91.13 - $142.5 $150,364 - $235,125
1,650 Added 0.65%
256,900 $26.9 Million
Q1 2019

May 15, 2019

BUY
$103.48 - $143.84 $1.47 Million - $2.05 Million
14,250 Added 5.91%
255,250 $32 Million
Q4 2018

Feb 14, 2019

SELL
$94.77 - $215.54 $9.57 Million - $21.8 Million
-101,000 Reduced 29.53%
241,000 $27.2 Million
Q3 2018

Nov 14, 2018

SELL
$207.3 - $300.31 $62,190 - $90,093
-300 Reduced 0.09%
342,000 $73.2 Million
Q2 2018

Aug 14, 2018

BUY
$101.55 - $313.9 $1.71 Million - $5.27 Million
16,800 Added 5.16%
342,300 $95.7 Million
Q1 2018

May 15, 2018

SELL
$93.35 - $149.04 $1.54 Million - $2.46 Million
-16,500 Reduced 4.82%
325,500 $38 Million
Q4 2017

Feb 14, 2018

BUY
$39.35 - $97.37 $2.64 Million - $6.52 Million
67,000 Added 24.36%
342,000 $31.4 Million
Q3 2017

Nov 14, 2017

BUY
$15.48 - $46.19 $4.26 Million - $12.7 Million
275,000
275,000 $12.4 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.02B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.